首页> Seminars in Arthritis and Rheumatism> Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)

Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)

导出原文传递

翻译打印收藏纠错

第一作者： Guido Junge

作者： Guido Junge ^[1] ; June Mason ^[2] ; Eugen Feist

作者单位： Novartis Pharma AG ^[1] Department of Rheumatology and Clinical Immunology, Charité-Universit?tsmedizin ^[2]

关键词 Adult-onset Still’s disease Anti-interleukin-1 treatment Steroid sparing DMARD sparing

发布时间 2020-11-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Seminars in Arthritis and Rheumatism

2017年47卷2期

295-302页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Seminars in Arthritis and Rheumatism

2017年47卷2期

295-302页

检索历史清除

Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)

Seminars in Arthritis and Rheumatism

相似文献

同项目论文

Seminars in Arthritis and Rheumatism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)

Seminars in Arthritis and Rheumatism

相似文献

同项目论文

Seminars in Arthritis and Rheumatism

相关期刊

检索历史清除